BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1310219)

  • 41. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
    Amador CA; Barrientos V; Peña J; Herrada AA; González M; Valdés S; Carrasco L; Alzamora R; Figueroa F; Kalergis AM; Michea L
    Hypertension; 2014 Apr; 63(4):797-803. PubMed ID: 24420551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic central potassium infusion prevents deoxycorticosterone-salt hypertension in rats.
    Klarr SA; Keep RF; Betz AL
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H646-52. PubMed ID: 7864190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of a calcium-enriched diet on salt-induced hypertension in rats.
    Garthoff B; Kazda S
    J Hypertens Suppl; 1985 Dec; 3(3):S433-4. PubMed ID: 2856758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of new inbred strains of Dahl-Iwai salt-sensitive and salt-resistant rats.
    Yamazaki K; Katoh H; Yamamoto N; Kurihara K; Iobe H; Sonoda J; Kuwabara M; Kodama M; Kawaguchi A; Funami Y
    Lab Anim Sci; 1994 Oct; 44(5):462-7. PubMed ID: 7844954
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ICV infusion of corticosterone antagonizes ICV-aldosterone hypertension.
    Gómez-Sánchez EP; Venkataraman MT; Thwaites D; Fort C
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E649-53. PubMed ID: 2333961
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertension and the mineralocorticoid receptor in the brain.
    Gómez Sánchez EP
    Ann N Y Acad Sci; 1994 Nov; 746():415-7. PubMed ID: 7825903
    [No Abstract]   [Full Text] [Related]  

  • 49. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension.
    Klanke B; Cordasic N; Hartner A; Schmieder RE; Veelken R; Hilgers KF
    Nephrol Dial Transplant; 2008 Nov; 23(11):3456-63. PubMed ID: 18515791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
    Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
    Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypertensive nephrosclerosis in the Dahl/Rapp rat. Initial sites of injury and effect of dietary L-arginine supplementation.
    Chen PY; St John PL; Kirk KA; Abrahamson DR; Sanders PW
    Lab Invest; 1993 Feb; 68(2):174-84. PubMed ID: 8441251
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
    Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
    J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Beneficial effects of proanthocyanidins in the cardiac alterations induced by aldosterone in rat heart through mineralocorticoid receptor blockade.
    Martín-Fernández B; de las Heras N; Valero-Muñoz M; Ballesteros S; Yao YZ; Stanton PG; Fuller PJ; Lahera V
    PLoS One; 2014; 9(10):e111104. PubMed ID: 25353961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Central interactions between aldosterone and vasopressin on cardiovascular system.
    Janiak P; Brody MJ
    Am J Physiol; 1988 Jul; 255(1 Pt 2):R166-73. PubMed ID: 2839996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of mineralocorticoid agonist and antagonist specific receptors from rat kidney.
    Agarwal MK; Kalimi M
    Biochem Biophys Res Commun; 1987 Feb; 143(1):398-402. PubMed ID: 3030321
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of antimineralocorticoid RU 26752 on steroid-induced hypertension in rats.
    Kalimi M; Opoku J; Agarwal M; Corley K
    Am J Physiol; 1990 May; 258(5 Pt 1):E737-9. PubMed ID: 2333987
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of aldosterone binding in aortic cells from Dahl salt-susceptible and salt-resistant rats.
    Nichols NR; Obert DF; Meyer WJ
    Life Sci; 1985 Apr; 36(17):1653-60. PubMed ID: 3157848
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pressure natriuresis and cortical and papillary blood flow in inbred Dahl rats.
    Roman RJ; Kaldunski M
    Am J Physiol; 1991 Sep; 261(3 Pt 2):R595-602. PubMed ID: 1887948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunization of Dahl SS/jr rats with an ouabain conjugate mitigates hypertension.
    Gomez-Sanchez EP; Gomez-Sanchez CE; Fort C
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):591-6. PubMed ID: 7946159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.